The Quiet Epidemic: Why Erectile Dysfunction Is Surging Among Young Men

Not an Old Man's Problem Anymore

For decades, erectile dysfunction (ED) was understood as an age-related condition — something that crept up on men after 60, mostly tied to heart disease, diabetes, or low testosterone. That picture has fundamentally changed.

A 2025 narrative review published in Cureus (PubMed Central) synthesized data from 1,981 published studies and found that ED in men under 40 is "increasingly reported" and that "its prevalence in this population remains underestimated." The review, which surveyed all peer-reviewed literature on the topic through 2025, found that rates as high as 35% have been reported in some young male populations.

The comparison to historical baselines is stark. A 1999 cross-sectional study cited in a 2016 Behavioral Sciences review found ED affected roughly 5% of sexually active men aged 18–59. A 2002 meta-analysis found consistent ED rates of approximately 2% in men under 40. Those figures were collected before internet "tube sites" made streaming pornography universally accessible — the first major video porn sites appeared in September 2006.

By 2011, a study of men aged 18–40 in Croatia, Norway, and Portugal — using the same survey question as earlier research — found ED rates ranging from 14% to 28%. A 2012 study of Swiss men aged 18–24 found a 30% rate using the standard International Index of Erectile Function (IIEF-5). A 2013 Italian clinical study reported that one in four patients seeking help for ED were under 40, with rates of severe ED nearly 10 percentage points higher than in older men. All of this data was compiled and reviewed in a 2016 Behavioral Sciences paper published in PubMed Central (PMC5039517).

A more recent U.S. study — the 2021 National Survey of Sexual Wellbeing, published in The Journal of Sexual Medicine in April 2024 — found that "a great deal of public speculation" about ED surging in younger men was not fully supported by its specific dataset, but acknowledged substantial prevalence data consistent with a growing trend in men under 40.

What the Numbers Actually Say

The most rigorously sourced U.S. data on young male ED comes from a study published in the Journal of Urology (PMC7790854), drawn from 2,660 sexually active men aged 18–31 from the 2013 Growing Up Today Study. The findings:

• 11.3% of sexually active men in the sample reported mild ED
• 2.9% reported moderate-to-severe ED
• Married or partnered men had 65% lower odds of ED compared to single men
• Antidepressant use was associated with more than 3 times the odds of moderate-to-severe ED
• Anxiety was independently associated with greater odds of moderate-to-severe ED
• Only 2% of young men reported using ED medication — but of those, 29.7% reported misusing prescription ED drugs

A separate 2014 Canadian study of adolescents aged 16–21, cited in the PMC5039517 review, found that 53.5% of males reported symptoms indicative of a sexual problem — with erectile dysfunction the most common at 26%, followed by low sexual desire (24%) and problems with orgasm (11%). The researchers described the findings as taking them "by surprise."

Among active-duty U.S. military personnel — a population considered relatively healthy — a 2014 cross-sectional study found an overall ED rate of 33.2% in men aged 21–40. A separate analysis of new ED diagnoses in active-duty servicemen found rates had more than doubled between 2004 and 2013, with psychogenic ED (rooted in psychological factors rather than physical disease) rising faster than organic ED.

The Causes: A Tangled Web

The 2025 Cureus narrative review (PMC12349891) identified several independent categories of cause:

Psychogenic factors: Performance anxiety, depression, relationship difficulties, and generalized anxiety are the most commonly cited psychological contributors to ED in young men. These are not new — what is new is the scale. Mental health conditions among young men have risen sharply in the past decade. Anxiety and depression in particular are both directly associated with ED in multiple population studies, and the Journal of Urology cohort study confirmed anxiety as an independent predictor of moderate-to-severe ED.

Pornography use: The relationship between internet pornography and ED has become one of the more debated areas in sexual medicine. The 2016 PMC5039517 review proposed that internet pornography's unique properties — unlimited novelty, easy escalation to more extreme content, video format — may condition sexual arousal to stimuli that "do not readily transition to real-life partners." The review cited clinical reports suggesting that stopping pornography use was sometimes sufficient to reverse sexual dysfunction, and it documented military and clinical case series in which men with no physical disease reported ED and low desire exclusively in partnered settings, while responding normally to pornography. The 2025 PMC narrative review listed pornography use as an independently documented lifestyle risk factor for ED alongside poor sleep quality, poor diet, and physical inactivity.

A 2021 JMIR Public Health study found a statistically significant association between online pornography consumption and sexual dysfunction in a multinational survey of young men. The causal mechanism proposed in multiple studies involves dopamine dysregulation: repeated high-stimulation exposure may reduce the brain's motivational response to real-world sexual cues.

Organic and metabolic factors: Not all young-male ED is psychological. The 2025 review documented organic contributors including endothelial dysfunction, hormonal imbalances (such as hypogonadism), metabolic syndrome, and neurogenic disorders. Cardiovascular risk factors — once considered exclusively a middle-aged concern — increasingly appear in young male ED patients. A March 2026 CNN Health report noted that the American Heart Association identifies sexual dysfunction as a potential early indicator of cardiovascular disease, sometimes appearing one to three years before classic symptoms such as angina.

Medications: Antidepressant use — particularly SSRIs — is among the most pharmacologically well-documented causes of sexual dysfunction in young men. A November 2025 New York Times investigation noted that sexual side effects of SSRIs in adults include "erectile dysfunction for men, elusive arousal for women and delayed and dulled orgasms," with research showing rates ranging from 30% to 80% depending on the symptom, drug, and duration of use. As antidepressant prescriptions to young men have increased, this pharmaceutical pathway to ED has grown proportionally.

COVID-19 aftermath: Yale medicine experts cited in a January 2025 Yale Daily News article pointed to COVID-19 as a possible lasting contributor, noting that pandemic-era isolation, disrupted social development, and post-COVID physiological effects may be reinforcing ED rates in cohorts who went through key developmental years during lockdowns.

The Stigma Problem

Medical researchers have identified a significant gap between prevalence and treatment-seeking. The Journal of Urology cohort found that only 2% of young men reporting ED were using any medication for it. The 2025 narrative review specifically noted that ED in young men "remains underestimated" as a clinical concern — partly because young men are less likely to disclose it, and partly because clinicians historically assumed it was a condition of older men.

The BBC has reported on the psychological toll: young men with ED frequently describe isolation, shame, and in some cases suicidal ideation — severe reactions tied to how closely erectile function is linked to male identity and self-worth. The condition is often hidden even from partners.

Researchers in the Journal of Urology study noted that health providers should "screen for ED in young men" as a standard clinical practice — a recommendation not yet widely implemented.

Treatment Options — and What the Research Supports

The 2025 PMC narrative review outlined the current treatment landscape for young men with ED:

First-line therapy remains phosphodiesterase type 5 inhibitors (PDE5i) — drugs such as sildenafil (Viagra) and tadalafil (Cialis). These are effective for most men regardless of cause, but do not address underlying psychological or behavioral factors.

For psychogenic ED, cognitive-behavioral therapy (CBT) and sex therapy have documented efficacy. Lifestyle modifications — exercise, improved diet, reduced alcohol and recreational drug use, better sleep — show consistent benefit in multiple studies.

For pornography-associated ED specifically, the behavioral intervention with the most clinical case support is simply cessation of pornography use. The PMC5039517 review documented multiple cases of full recovery without medication following abstinence from internet pornography.

Emerging therapies under investigation include low-intensity extracorporeal shockwave therapy, stem cell injections, and platelet-rich plasma (PRP) therapy — all targeting tissue regeneration rather than symptomatic management. As of 2025, these remain experimental.

For hormone-related ED, testosterone replacement therapy is appropriate when hypogonadism is confirmed through lab testing. The 2025 review emphasized that laboratory evaluation — including HbA1c for diabetes, lipid panels for hypercholesterolemia, and testosterone/prolactin/thyroid hormone panels — should be part of any comprehensive ED workup in young men, not assumed psychological.

The Bigger Picture

The surge in ED among young men sits within a broader deterioration of male sexual and mental health metrics across developed countries. Sperm counts have declined significantly in Western nations over the past four decades, according to a 2022 meta-analysis in Human Reproduction Update. Testosterone levels in young men have trended downward in population studies. Male suicide rates remain far above female rates across most age groups. Loneliness and social isolation among men under 35 have risen sharply since 2000, according to data from the American Perspectives Survey.

ED, in this context, is both a symptom and a signal — a measurable, physiologically grounded indicator that something is going wrong across a generation of men. Whether the primary driver is pornography, anxiety, metabolic change, medication side effects, or some combination of all four, the research consensus is unambiguous: this is not a rare condition, it is not confined to older men, and it is not improving on its own.